The Safety of Testosterone Therapy in Women
| Autor: | Lina Al-Imari, Wendy Wolfman |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Canada Pediatrics medicine.medical_specialty Female sexual dysfunction Personal distress Breast Neoplasms Bone Density medicine Humans Testosterone Sexual Dysfunctions Psychological Libido Gynecology business.industry Obstetrics and Gynecology Hypoactive sexual desire disorder Testosterone (patch) Middle Aged medicine.disease Lipids Endometrial Neoplasms Clinical trial Menopause Affect Sexual Dysfunction Physiological Cardiovascular Diseases Female Chemical and Drug Induced Liver Injury business Psychosocial |
| Zdroj: | Journal of Obstetrics and Gynaecology Canada. 34:859-865 |
| ISSN: | 1701-2163 |
| DOI: | 10.1016/s1701-2163(16)35385-3 |
| Popis: | Hypoactive sexual desire disorder (HSDD), a subset of female sexual dysfunction, causes personal distress for surgically and naturally postmenopausal and premenopausal women. HSDD has a multifactorial etiology, including psychosocial factors such as relationship issues and medical factors such as medications, chronic illnesses, and hormonal effects. Although no androgen therapies for female sexual dysfunction are currently approved for use in Canada, clinical trials support the efficacy and short-term safety of testosterone therapy for HSDD. We review the scientific evidence for the safety of testosterone therapy for HSDD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|